Clinical Trial Update: Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of RGH-188 (cariprazine) in bipolar depression; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder - Bipolar Depression

Drugs mentioned

• RGH-188

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-08-23